Comparative and functional genomics of Toxoplasma and Hammondia hammondi
弓形虫和 Hammondia hammondi 的比较和功能基因组学
基本信息
- 批准号:10267775
- 负责人:
- 金额:$ 38.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-15 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemAcuteAdoptedAdultAnimal ModelAnimalsAntiparasitic AgentsAutomobile DrivingBiologyBloodCandidate Disease GeneCell AgingCell CycleCellsChildComplementCystDNA DamageDataDevelopmentDevelopmental GeneDiseaseFetal DevelopmentFoundationsFundingGene Expression RegulationGenesGeneticGoalsGrowthGrowth and Development functionHost DefenseImmune responseImmunosuppressionInfectionInflammatoryInflammatory ResponseInnate Immune ResponseLife Cycle StagesLinkMasksModelingMolecularOrganismOutcomeParasitesPathogenesisPathway interactionsPatientsPhenotypePlacentaRefractoryRegulationRegulatory PathwaySignal PathwaySporozoitesStressSyntenySystemTestingTherapeutic InterventionToxoplasmaToxoplasma gondiiToxoplasmosisTransgenic OrganismsVirulenceVirulence FactorsWorkbasecomparativecomparative genomicsepigenomicsexperienceexperimental studyfollow-upfunctional genomicshuman diseasehuman pathogenin vitro Assayinnovationknockout genenew therapeutic targetnovelnovel therapeutic interventionnucleic acid binding proteinobligate intracellular parasiteopportunistic pathogenpreventresponsesuccesstraittranscriptome sequencingtranscriptomics
项目摘要
PROJECT SUMMARY/ABSTRACT:
Toxoplasma gondii is an important opportunistic pathogen of humans where it can cause severe disease in the
developing fetus and those with HIV/AIDS. Parasite development is critical for its ability to cause severe
disease, yet the precise mechanisms for how it does this are poorly understood. T. gondii is also modulates the
cell that in infects via secretion of a multitude of effectors. Much of the work aimed at understanding how T.
gondii is able to cause disease has focused exclusively on T. gondii itself. An innovative alternative to this
approach is to perform functional and genetic comparisons between T. gondii and its near relatives to reveal
previously unknown mechanisms of parasite virulence and developmental regulation. The parasite Hammondia
hammondi is one such relative, and our work in the prior funding period has developed this organism into a
powerful comparative model for probing T. gondii biology from an evolutionary context. In this renewal we
follow up on two observations from the prior funding period: 1) that T. gondii is unique in its ability to
facultatively regulate its conversion to the quiescent cyst stage and 2) that T. gondii is unique in its ability to
alter the host cell cycle and that this may be linked to suppression of host anti-parasitic responses. In Aim 1 we
use a focused RNAseq screen to identify new regulators of T. gondii development, using H. hammondi as a
natural filter to focus on relevant candidate genes. Success of this Aim is facilitated by the use of new
transgenic approaches for H. hammondi and preliminary data supporting the premise of our candidate based
approach. In Aim 2 we determine how T. gondii and H. hammondi differentially regulate changes in the
infected host cell, with a focus on underappreciated host pathways including DNA damage responses and
cellular senescence. Success of this aim is facilitated by our extensive experience with T. gondii and H.
hammondi sporozoites and in vitro assays, as well as transgenic approaches in H. hammondi that will permit
us to perform the first ever cross-species complementation experiments in this organism. Overall these studies
build on work during the prior funding period aimed at identifying important phenotypic differences between
these closely related parasite species and then determining their molecular mechanisms. We expect these
studies to result in new discoveries of how T. gondii regulates in growth and development and how it is able to
suppress a wide variety of host defenses. Both of these lines of inquiry will identify new avenues for
therapeutic intervention, whether they target the parasite itself or host responses found to be critical for its
survival.
项目总结/摘要:
弓形虫是人类重要的条件致病菌,可引起严重的疾病,
发育中的胎儿和艾滋病毒/艾滋病患者。寄生虫的发育对于其引起严重的
疾病,但它如何做到这一点的确切机制知之甚少。T.弓形虫也调节
通过分泌大量效应物感染的细胞。大部分工作旨在了解T.
弓形虫能够引起疾病的研究主要集中在T。gondii本身一个创新的替代方案,
方法是进行T.弓形虫及其近亲揭示
以前未知的寄生虫毒力和发育调节机制。Hammondia寄生虫
哈蒙迪就是这样一个亲戚,我们在前一个资助期的工作已经将这种生物体发展成为一种
一个强大的比较模型来探测T.弓形虫生物学的进化背景。在这次更新中,我们
跟踪上一个资助期的两个观察结果:1)T。弓形虫的独特之处在于,
兼性细胞调节其向静止包囊期的转化;弓形虫的独特之处在于,
改变宿主细胞周期,这可能与抑制宿主抗寄生虫反应有关。在目标1中,
使用聚焦RNAseq筛选来鉴定T. gondii的发育,利用H.哈蒙迪
自然过滤器,专注于相关的候选基因。这一目标的成功是通过使用新的
转基因方法哈蒙迪和初步数据支持的前提下,我们的候选人的基础
approach.在目标2中,我们确定T. gondii和H.哈蒙迪差异调节的变化,
感染的宿主细胞,重点关注未被充分认识的宿主途径,包括DNA损伤反应,
细胞衰老我们在T方面的丰富经验有助于这一目标的成功。gondii和H.
hammondi子孢子和体外测定,以及在H.哈蒙迪将允许
让我们在这种生物体中进行首次跨物种互补实验。总体而言,
建立在前一个资助期的工作,旨在确定重要的表型差异之间
这些密切相关的寄生虫物种,然后确定它们的分子机制。我们预计这些
研究的新发现,T.弓形虫调节生长和发育,以及它如何能够
抑制各种宿主防御这两条调查路线将为以下方面确定新的途径:
治疗性干预,无论是针对寄生虫本身还是宿主反应,
生存
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JON P BOYLE其他文献
JON P BOYLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JON P BOYLE', 18)}}的其他基金
Placental resistance and response to the teratogenic pathogen Toxoplasma gondii
胎盘对致畸病原体弓形虫的抵抗力和反应
- 批准号:
10600051 - 财政年份:2022
- 资助金额:
$ 38.35万 - 项目类别:
Placental resistance and response to the teratogenic pathogen Toxoplasma gondii
胎盘对致畸病原体弓形虫的抵抗力和反应
- 批准号:
10453973 - 财政年份:2022
- 资助金额:
$ 38.35万 - 项目类别:
Finishing multiple genomes in EupathDB using Oxford Nanopore Single Molecule sequencing
使用 Oxford Nanopore 单分子测序在 EupathDB 中完成多个基因组
- 批准号:
10188420 - 财政年份:2020
- 资助金额:
$ 38.35万 - 项目类别:
Comparative and functional genomics of Toxoplasma and Hammondia hammondi
弓形虫和 Hammondia hammondi 的比较和功能基因组学
- 批准号:
10750395 - 财政年份:2015
- 资助金额:
$ 38.35万 - 项目类别:
Comparative and functional genomics of Toxoplasma and Hammondia hammondi
弓形虫和 Hammondia hammondi 的比较和功能基因组学
- 批准号:
10461884 - 财政年份:2015
- 资助金额:
$ 38.35万 - 项目类别:
Comparative and functional genomics of Toxoplasma and Hammondia hammondi
弓形虫和 Hammondia hammondi 的比较和功能基因组学
- 批准号:
9090012 - 财政年份:2015
- 资助金额:
$ 38.35万 - 项目类别:
Comparative and functional genomics of Toxoplasma and Hammondia hammondi
弓形虫和 Hammondia hammondi 的比较和功能基因组学
- 批准号:
10772454 - 财政年份:2015
- 资助金额:
$ 38.35万 - 项目类别:
Comparative and functional genomics of Toxoplasma and Hammondia hammondi
弓形虫和 Hammondia hammondi 的比较和功能基因组学
- 批准号:
10669739 - 财政年份:2015
- 资助金额:
$ 38.35万 - 项目类别:
Comparative and functional genomics of Toxoplasma and Hammondia hammondi
弓形虫和 Hammondia hammondi 的比较和功能基因组学
- 批准号:
9282262 - 财政年份:2015
- 资助金额:
$ 38.35万 - 项目类别:
Comparative and functional genomics of Toxoplasma and Hammondia hammondi
弓形虫和 Hammondia hammondi 的比较和功能基因组学
- 批准号:
8861405 - 财政年份:2015
- 资助金额:
$ 38.35万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 38.35万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 38.35万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 38.35万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 38.35万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 38.35万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 38.35万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 38.35万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 38.35万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 38.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 38.35万 - 项目类别:
Standard Grant